Cryptocurrency Stellar Down More Than 6% Within 24 hours

Over the past 24 hours, Stellar's (CRYPTO: XLM) price has fallen 6.69% to $0.13. This is opposite to its positive trend over the past week where it has experienced a 29.0% gain, moving from $0.10 to its current price.

Over the past 24 hours, Stellar’s (CRYPTO: XLM) price has fallen 6.69% to $0.13. This is opposite to its positive trend over the past week where it has experienced a 29.0% gain, moving from $0.10 to its current price.

The chart below compares the price movement and volatility for Stellar over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.

price_chart

The trading volume for the coin has increased 481.0% over the past week. while the overall circulating supply of the coin has decreased 0.12% This puts its current circulating supply at an estimated 54.28% of its max supply, which is 50.00 billion. The current market cap ranking for XLM is #23 at $3.46 billion.

supply_and_vol

Powered by CoinGecko API

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Tesla Unleashes New Blitz In EV Price Battle, Bezos’ Megayacht Update, And Bitcoin Surge On The Horizon: 5 Key Stories You May Have Missed From The Weekend

The long weekend on account of the Good Friday holiday passed off quietly with scaled-back news flow and less chatter on social media. Here’s a recap of a few major headlines that hit the wire over the weekend and that may have implications for the market:

AAPL

Read More

EXCLUSIVE: Medical Marijuana, Inc. Subsidiary HempMeds Working With Argentine Research Hospital On CBD For Adult Epilepsy

Medical Marijuana, Inc. (OTC: MJNA), the first publicly-traded cannabis company to launch cannabis-derived nutraceutical products, brands, and supply chains announced that its subsidiary HempMeds is collaborating with Hospital del Cruce to conduct a study in Argentina on the efficiency of CBD

MJNA